| Customization: | Available |
|---|---|
| Certification: | CE |
| Disinfection: | Disinfection |
|
Still deciding? Get samples of US$ 70/Piece
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
The skin may regenerate its own collagen naturally due to it's Collagenesis-Enabled Solubilized Active Biodegradable Polymer Technology without the utilization of microparticles. This PCL that has been entirely solubilized distributes quickly over the large area of the skin. Therefore, it won't be necessary to inject at different sites, and a very thin 30G needle is suggested. In comparison to other goods, it has relatively less discomfort and downtime because of these qualities.
Usage:
Subcutaneous Layer, Dermis
Primary advantages:
Less unpleasant
Safer than other products
It allows natural skin collagen regeneration in the skin without the need for microparticles
It has relatively less pain and downtime
It has long-lasting effects
Synergy effect with other products: Toxin or Filler + this product = longer duration and natural look with lifting, and Ulthera + this product = Strong Collagen generation with moisturizing
filler(2ml * 5 vials): It has Collagen stimulation and skin radiance effects DLMR HA (2ml * 5 vials): It has Collagen stimulation and skin radiance effects.
It is developed and produced by Dexlevo, a aesthetic medicine company specializing in the development of soluble biodegradable polymer technology.
Each ampoule contains 30% PCL (polycaprolactone), which is extremely pure. As a new type of filler, PCL has good biodegradability, and it is the main raw material for thread carving and medical absorbable suture.
Soluble PCL only needs to be applied on the face at 8~10 points, and it can naturally spread to all parts of the skin, which can reshape the facial structure, promote collagen, and has the effects of lifting and firming, restoring elasticity, and slowing down skin aging. The effect is more durable and stable compared with other lifting products on the market.
There are a lot of hyaluronic acid dermal filler in the market, however the duriation time is not long.
However, the product like BDDE or DVS cross linked hyaluronic acid particles and commonly used polymer products (polylactic acid and polycycloacetone) last longer but are not easy to degrade. And this microparticle product has the risk of vascular embolism, and it is not easy to spread in the skin, so it can only be used on some part of the face.
Dexlevo pioneered the CESABP patented technology (full name: Colengisation-International Solubilized Active and Biodletablection Polmer), and developed the easily biocompatible and biodegradable polymer PCL.
Main Function:
Full Layer Anti-aging
PCL can stimulate fibroblasts and promote the synthesis and regeneration of natural collagen. Eight-point boost will be a "new generation anti-aging" collagen stimulator, which can effectively deal with aging skin.
Firming
It directly promotes the regeneration of collagen molecules, reorganizes, repairs and tightens the loose superficial fascia fat cell chains, so as to achieve a lifting effect.
Enhance elasticity
Effectively promote the regeneration of subcutaneous collagen and elastin, restore the skin's elasticity, regain its youthful state, and make the skin firm, lifted, plump and youthful.
Anti wrinkle
After the biodegradable PCL enters the human body, the cortical filler forms an extensive 3D matrix, which can be completely absorbed by the human body, effectively promotes the regeneration of natural collagen, and continuously reduces fine lines and wrinkles.
Direction for Use
Suggested needle: 30~34G sharp needle (13mm)
Needle entry method: vertical needle entry
Suggested dosage: 0.2~0.5cc/per point
Recommended depth: 5~8mm deep dermis on the forehead; 8~10mm deep dermis on the cheeks.
Suggested course of treatment: 2 courses of treatment in 1 year, 2 times for each course of treatment, 1 bottle each time. The second dose was given one month later, and the course of treatment was repeated six months later.
Before & After:
Experimental data:
No definite nodules were found after 8 h in the DLMR01 group. Throughout the 12-week testing period, dermatologists observed no overt signs of inflammatory erythema, swelling, and pus. Furthermore, delayed responses including nodule formation and granulomas were not detected in either group. Therefore, both PBS and DLMR01 were considered to be well tolerated.
){kind=link}